EARA (European Animal Research Association) supports call to end embargo by transport providers in the UK and US on animal research @ Transplant Method Avoids Rejection of Donor Leg for Months in Rats – A proof-of-concept study uses a strategy similar to the way tumors evade immune detection. The new limbs survive for more than 200 days. @ How long does it take to create a vaccine? It usually takes between 10-15 years to develop a vaccine but the global response to COVID19 has sped up the process considerably #CelebrateVaccines #animalresearch @ Very important images, including messages in lives I typed and links about relevant issues @ FDA authorizes 15-minute coronavirus test By Arman Azad, CNN @ Scientists discover new kind of light that breaks limits of natural law – ‘Super-Planckian’ material emits light that goes beyond the limits of natural law – Web Desk March 25, 2020 12:51 IST &@ Links about ´´my´´ Dissertation, ´´my´´ Monograph and Animal Models for Human Diseases like Cardiovascular Diseases

Do the downloads!! Share!! The diffusion of very important information and knowledge is essential for the world progress always!! Thanks!!

  • – > Mestrado – Dissertation – Tabelas, Figuras e Gráficos – Tables, Figures and Graphics´´My´´ Dissertation @ #Innovation #energy #life #health #Countries #Time #Researches #Reference #Graphics #Ages #Age #Mice #People #Person #Mouse #Genetics #PersonalizedMedicine #Diagnosis #Prognosis #Treatment #Disease #UnknownDiseases #Future #VeryEfficientDrugs #VeryEfficientVaccines #VeryEfficientTherapeuticalSubstances #Tests #Laboratories #Investments #Details #HumanLongevity #DNA #Cell #Memory #Physiology #Nanomedicine #Nanotechnology #Biochemistry #NewMedicalDevices #GeneticEngineering #Internet #History #Science #World

Pathol Res Pract. 2012 Jul 15;208(7):377-81. doi: 10.1016/j.prp.2012.04.006. Epub 2012 Jun 8.

The influence of physical activity in the progression of experimental lung cancer in mice

Renato Batista Paceli 1Rodrigo Nunes CalCarlos Henrique Ferreira dos SantosJosé Antonio CordeiroCassiano Merussi NeivaKazuo Kawano NagaminePatrícia Maluf Cury


Impact_Fator-wise_Top100Science_Journals

GRUPO_AF1GROUP AFA1 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

GRUPO AFAN 1GROUP AFAN1 – Anaerobic Physical ActivityAtividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

GRUPO_AF2GROUP AFA2 – Aerobic Physical ActivityAtividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

GRUPO AFAN 2GROUP AFAN 2 – Anaerobic Physical ActivityAtividade Física Anaeróbia´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

Slides – mestrado´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

CARCINÓGENO DMBA EM MODELOS EXPERIMENTAIS

DMBA CARCINOGEN IN EXPERIMENTAL MODELS

Avaliação da influência da atividade física aeróbia e anaeróbia na progressão do câncer de pulmão experimental – Summary – Resumo´´My´´ Dissertation Faculty of Medicine of Sao Jose do Rio Preto

https://pubmed.ncbi.nlm.nih.gov/22683274/

Abstract

Lung cancer is one of the most incident neoplasms in the world, representing the main cause of mortality for cancer. Many epidemiologic studies have suggested that physical activity may reduce the risk of lung cancer, other works evaluate the effectiveness of the use of the physical activity in the suppression, remission and reduction of the recurrence of tumors. The aim of this study was to evaluate the effects of aerobic and anaerobic physical activity in the development and the progression of lung cancer. Lung tumors were induced with a dose of 3mg of urethane/kg, in 67 male Balb – C type mice, divided in three groups: group 1_24 mice treated with urethane and without physical activity; group 2_25 mice with urethane and subjected to aerobic swimming free exercise; group 3_18 mice with urethane, subjected to anaerobic swimming exercise with gradual loading 5-20% of body weight. All the animals were sacrificed after 20 weeks, and lung lesions were analyzed. The median number of lesions (nodules and hyperplasia) was 3.0 for group 1, 2.0 for group 2 and 1.5-3 (p=0.052). When comparing only the presence or absence of lesion, there was a decrease in the number of lesions in group 3 as compared with group 1 (p=0.03) but not in relation to group 2. There were no metastases or other changes in other organs. The anaerobic physical activity, but not aerobic, diminishes the incidence of experimental lung tumors.

@ Internet – History – World – Person – People – Cities – Ideas – Projects – Researches – Name – Link – Photo – Videos – Images – Texts – Message – Feelings – Thinking – Website – Time – E-mail – Information – Reading – Typing – Probability – Energy – Memory – Longevity

* Link about my monograph: Induction of benzonidazole resistance in human isolates of Trypanosoma cruzi: https://science1984.wordpress.com/2018/07/15/my-monography-chagas-disease-research-in-laboratory-2/

 

-Link about animal model diseases like cardiovascular diseases: https://science1984.wordpress.com/2020/04/29/33426/

 

– Links related with my dissertation: https://science1984.wordpress.com/2019/11/28/links-of-my-dissertation-the-influence-of-physical-activity-in-the-progression-of-experimental-lung-cancer-in-mice-and-monograph-induction-of-benzonidazole-resistance-in-human-isolates-of-trypanoso/

https://science1984.wordpress.com/2019/11/29/about-my-dissertation-the-influence-of-physical-activity-in-the-progression-of-experimental-lung-cancer-in-mice-pathol-res-pract-2012-jul-152087377-81-doi-10-1016-j-prp-2012-04-006-epub-20/

https://science1984.wordpress.com/2018/07/15/i-did-very-important-detailed-and-innovative-graphics-about-variations-of-all-mice-weigths-during-all-exerimental-time-my-dissertation-they-can-be-an-excelent-reference-for-future-researches-like-2/

https://science1984.wordpress.com/2019/03/08/it-is-fundamental-professors-students-researchers-and-other-people-worldwide-know-about-my-dissertation-because-the-research-was-very-innovative-and-important-in-the-world-these-data-like-graphics/

 

https://www.theweek.in/news/sci-tech/2020/03/25/scientists-discover-new-kind-of-light-breaks-limits-of-natural-law.html?fbclid=IwAR3KC0Aqi1uK_9YOYDdp-yoCxUt-io0eBFlreSiSUqf8WMWR6M4S7_Zd1mk

https://edition.cnn.com/2020/03/27/us/15-minute-coronavirus-test/index.html?utm_medium=social&utm_content=2020-03-28T21%3A00%3A05&utm_term=link&utm_source=fbCNN&fbclid=IwAR3PXS1jPsX4kYANIl1iNFSAdrJ_FWj5fjsXjgLv7n0Zfet1anNhQ_n9R_0

https://www.scientificamerican.com/article/coronavirus-vaccines-may-not-work-for-the-elderly-and-this-lab-aims-to-change-that/?utm_medium=social&utm_content=organic&utm_source=facebook&utm_campaign=SciAm_&sf231976874=1&fbclid=IwAR0usRkUQLyHCwNgp16hSjWLzhYpg1r1RTvNj6DllolaoIbVThJItrW5KaM

https://www.forbes.com/sites/alexandrasternlicht/2020/03/24/bill-gates-on-covid-19-best-case-scenario-is-6-to-10-weeks-of-total-isolation-in-us/?utm_campaign=forbes&utm_source=facebook&utm_medium=social&utm_term=Gordie%2F&fbclid=IwAR0FxHvzvaDdNiMRdP9Dze0MZlO-A1I1zwxivCpR-leSw_37ZLsYvD1idDE#5e527077740e

https://www.wsj.com/articles/trumps-leadership-11585175446?mod=e2fb&fbclid=IwAR1_1ewo6CofgN0B3ZPJWHaTFV0p1Xu7Qc3xyYLQ6CYRGSkPij_x1O332_s

http://news.mit.edu/2020/white-house-supercomputing-covid-19-0323

https://teletype.in/@healthinnovation/vvs2zGeg3?fbclid=IwAR3K9riqhlRZZSDK6nCmLDPEvVbEPRebgNonoMRMikHKdwIRBSDWNHGDCCA

https://www.facebook.com/scientificblog/

http://www.twitter.com/CalZole

https://www.linkedin.com/in/rodrigo-nunes-cal-81433b168/

https://www.eara.eu/post/eara-supports-urgent-action-to-end-animal-research-embargo-by-transport-providers-in-the-uk-and-us?fbclid=IwAR1NZ5QClR8P9Fj3252vWkuyN09DY3fngM6t2uyE8AiZ3_v6hKP4WX0XYMA

https://www.instagram.com/calrodrigonunes/

https://www.foxbusiness.com/money/to-conserve-cash-during-coronavirus-crisis-gm-temporarily-cuts-20-of-salaries-for-69000-workers?fbclid=IwAR19lmoEUxTns3-CzTxqXp8MN0QIjFmORAatyVYXdyx_0yarCRgAh0Ouq2g

https://www.scientificamerican.com/article/some-states-are-reporting-incomplete-covid-19-results-blurring-the-full-picture/?utm_medium=social&utm_content=organic&utm_source=facebook&utm_campaign=SciAm_&sf231950793=1&fbclid=IwAR0NNoVsql33jKhSQP1hZYuW8CDlwsxOdEGSCoAE7XToipTdB0nlW0E_Eek

https://www.the-scientist.com/news-opinion/transplant-method-avoids-rejection-of-donor-leg-for-months-in-rats-67265?utm_campaign=TS_DAILY+NEWSLETTER_2020&utm_source=hs_email&utm_medium=email&utm_content=84780701&_hsenc=p2ANqtz-9YUtzMzsZyNJe29ejmy-j4ih6bLgRqh4I19b-bdw62nzwANxMf6xrSEtuh4PK_Eo6ghc3nMlG7gB6IOeagM5nixDPl5Q&_hsmi=84780701&fbclid=IwAR2-RUwTvRbeSnPJhlVMEMERRY5-2oTnMm38gh79RWsknkFH75-p0KVoFXM

https://www.linkedin.com/in/kirkleech/

https://www.facebook.com/The.EARA/

https://www.instagram.com/rodrigoncal84/

https://www.foxbusiness.com/healthcare/us-leads-in-coronavirus-cases-worldwide?fbclid=IwAR0_WryJ0XxFS9OlIWZ1XY2ySIsxsKLtrKhWO87OwvJbnC8fiMZIKwLnox4

77777777777777777777777777777

78456a1aa2a3a4a5a6a7a8a9a21a

456a1aa2a5a

7345643ffff1fff2fff3fff4fff5fff6fff7fff8fff9fff21fff43fff456fff456p754fff754ffffff856fff4567fff7546fff

4a5a6a7a8a9a11a12acomment6436billgates53464commentsbilgates635473457covid19curi2curyearaeara33eara65eara345eara4333eara75757eara645754eara868679eara5657567eara475754854EARA-POSTEARA-POST5faucifauci87fauci75754linkedinLINKEDIN565linkedin645linkedin6547547linkedin64356456linkedin65745658live44live677opinionpete1

Transplant Method Avoids Rejection of Donor Leg for Months in Rats

Transplant Method Avoids Rejection of Donor Leg for Months in Rats

A proof-of-concept study uses a strategy similar to the way tumors evade immune detection. The new limbs survive for more than 200 days.

Abby Olena
Mar 13, 2020

 

814

ABOVE: This white rat received a donor leg from a brown rat along with microparticles that release a protein that trains the immune system to accept the foreign tissue.
UPMC

Getting any kind of transplant typically means taking multiple immune-suppressing drugs forever after to avoid rejection of the donor organ or tissue. A study published today (March 13) in Science Advances demonstrates a way around long-term immune suppression. The researchers injected microparticles that release a protein that recruits regulatory T cells to train the immune system of rats receiving a donor limb to recognize the foreign tissue as self instead of non-self.

The conventional immunosuppression strategy after transplantation comes with “a lot of side effects and complications down the line, but I think we’ve now realized that we need to shift this and this [study] is one testimony to this,” says Gerald Brandacher, a surgeon who specializes in upper extremity and face transplantation at Johns Hopkins University School of Medicine and was not involved in the work. “In these first small animal models, we see proof of concept that [immune regulation] strategies can work, and hopefully down the road will lead to a much better way to actually navigate the immune system in the setting of transplantation.”

The concept of training the immune system to ignore tissue came from tumors, says Steven Little, a bioengineer at the University of Pittsburgh. He points to previous work from the last couple of decades showing that tumors can recruit the body’s own regulatory T cells by releasing the protein CCL22, which then leads to a decrease in immune recognition of the tumor. He says he thought that it would be possible to engineer a therapeutic that would release CCL22 synthetically and “create something that’s not a tumor, but still tricks the body into accepting something that would otherwise be rejected, like a transplant.”

Years of work led to the current study in rats. Little and colleagues transplanted hindlimbs from brown rats onto the bodies of white rats. They treated all the rats with an immunosuppression drug for 21 days, and some of them also got one of three possible doses of biodegradable microparticles containing synthetic mouse CCL22, CCL22 protein alone, or empty microparticles, each injected under the skin of the donor limb. There was also a control group that received an injection of microparticles containing CCL22 in the unaffected hindlimb.

Within the first 50 days, all the donor limbs had been rejected, except in the rats that received either the medium or high dose of CCL22-loaded microparticles. The researchers gave another microparticle injection 21 days after the transplant and confirmed that CCL22 was released for 40 days. In six of the eight rats that received the medium dose of these microparticles, the donor limbs survived for much longer—more than the 200 days of the experiment. The medium dose worked better than the high dose: only two of those animals had a surviving graft by day 60 and only one had a surviving graft for the duration of the experiment.

The authors found that there was a higher percentage of regulatory T cells among all the T cells in the grafts that survived compared to the ones that didn’t. Plus, the accepted donor limbs had a lower abundance of pro-inflammatory genes than the ones that were rejected. The recipients’ immune systems not only accepted the transplanted limbs, but also accepted a skin graft from a donor of the same strain as their limb donor. The acceptance of the skin graft happened in the absence of immunosuppression, and the recipients completely rejected a skin graft from another rat strain. This indicates that the recognition of that particular set of foreign antigens as self is ongoing.

“Through the transplantation procedure we have effectively reeducated the rat’s immune system to now accept this donor’s whole host or repertoire of antigens,” says Little. “We’ve convinced that immune system that that [donor] is now self too, but the immune system is still competent so if you give it a third animal’s antigen, it rejects that.”

“The graft survival data with the hindlimb transplant in the rat is quite impressive,” both in this study and another one the authors published last year in PNASsays Christene Huang, who studies alternatives to prolonged immunosuppression after transplants at the University of Colorado Anschutz Medical Campus and did not participate in the work.

She cautions that some strategies that work to induce tolerance of foreign tissue when that tissue comes from a living donor fail when the tissue comes instead from a brain-dead donor, as is the case in human limb and face transplants. It’s not well understood why there’s a difference, but that’s an open question that could influence this strategy’s efficacy going forward. Another question, she says, is how well the microparticles will work in larger animals.

Testing the approach in pigs is next, according to coauthor Jim Fisher, a graduate student in Little’s lab. If it makes sense, they’ll then move toward studies of safety and efficacy in people. “We’re releasing a protein from the microparticles, but that’s not really the medicine,” he says. The protein is then recruiting the body’s “own cells that are actually acting as the medicine, which is fundamentally different than anything that is used right now in transplants.”

J.D. Fisher et al., “In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation,” Science Advancesdoi:10.1126/sciadv.aax8429, 2020. 

Abby Olena is a freelance journalist based in Alabama. Find her on Twitter @abbyolena.

Keywords:

disease & medicine
immune rejection
immune suppression
immunology
News
transplants
tumor immunology

The Scientist's Current Issue's Magazine Cover

MARCH 2020

Rising Seas, Dead Trees

Ghost forests are a warning about climate change

Genes that Escape Silencing on the Second X Chromosome May Drive Disease
Genes that Escape Silencing on the Second X Chromosome May Drive Disease
When X-linked genes evade silencing on the “inactive” chromosome in XX cells, some protect women from diseases such as cancer, but others seem to promote conditions such as autoimmunity.
Climate Change Is Killing East Coast Forests
Climate Change Is Killing East Coast Forests
As the salty Atlantic Ocean pushes farther inland, forests are turning to marsh. Some scientists want to speed the transition.
Can Destroying Senescent Cells Treat Age-Related Disease?
Can Destroying Senescent Cells Treat Age-Related Disease?
A handful of clinical trials are underway to find out whether drugs that target senescent cells can slow the ravages of old age.
Marketplace

Sponsored Product Updates

Measuring Cytopathic effects from Viral Infections by Applied BioPhysics Inc.
Measuring Cytopathic effects from Viral Infections by Applied BioPhysics Inc.
Cytopathic effects of viral infections upon cultured cells are difficult to quantify due to the subjective nature of monitoring cell morphology.
Synthego Receives ELRIG Technology Award for Company’s Arrayed CRISPR Screening Libraries
Synthego Receives ELRIG Technology Award for Company’s Arrayed CRISPR Screening Libraries
Presented at ELRIG’s CRISPR in Drug Discovery 2020, the Award Underscores the Impact of Synthego’s Screening Libraries to Support Full Continuum of Therapy Discovery and Development
Gyrolab technology to be incorporated into Jefferson Institute for Bioprocessing specialized teaching curriculum and training programs
Gyrolab technology to be incorporated into Jefferson Institute for Bioprocessing specialized teaching curriculum and training programs
Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and the Jefferson Institute for Bioprocessing (JIB) at Thomas Jefferson University, a leading center of excellence providing advanced training to the bioprocessing industry, today announced that Gyrolab xPlore™ immunoassay system from Gyros Protein Technologies will be integrated into JIB’s curriculum.
TTP plc, NHS Highland and The University of the Highlands and Islands to partner on atrial fibrillation clinical data collection and analysis project
TTP plc, NHS Highland and The University of the Highlands and Islands to partner on atrial fibrillation clinical data collection and analysis project
– Collaboration aims to develop scoring algorithms to enable better clinical management of patients with atrial fibrillation
– Data will help determine patient suitability for treatment with electrical cardioversion therapy